Month: April 2019
-
Research
Diasome’s Liver Targeted Insulin
We spoke with Robert Geho, CEO of Diasome Pharmaceuticals, Inc. — www.diasome.com — about its nanotechnology additive that delivers insulin…
Read More » -
Treatment
Overnight Dosing Success in T1D Children
We spoke with Ulrike Schierloh, MD who is with the Pediatric Clinic, Centre Hospitalier de Luxembourg, Luxembourg, GD de Luxembourg…
Read More » -
Research
Aaron Kowalski Appointed New JDRF President/CEO
Today, the JDRF announced the appointment of Aaron J. Kowalski, Ph.D., as the nonprofit’s President and Chief Executive Officer. A…
Read More » -
Living
How I Fulfilled My Dream of Natural Childbirth Despite My T1D
I have never let diabetes dictate my life. I’ve climbed mountains, RVed across foreign countries and traveled all over the…
Read More » -
Medicine/Drugs
Basal Insulins Explained
Many people with diabetes have developed a love-hate relationship with insulin. This life-saving, wallet-shrinking, high-fixing, low-causing, pain-to-dose wonder molecule is…
Read More » -
Research
Oxygen Critical to Practical Islet Transplants
We spoke with Klearchos Papas, PhD about his oxygen generator-based islet ‘tea bag’ transplant device for which the JDRF just…
Read More »